Dr. Dixon on Advances in Axillary Node Procedures

Video

Dr. J. Michael Dixon from the University of Edinburgh on Advances in Breast Cancer Axillary Node Procedures

J. Michael Dixon, MBChB, MD, Professor of Surgery and Consultant Surgeon of the University of Edinburgh; and Clinical Director of the Edinburgh Breast Unit at the Western General Hospital in Edinburgh, Scotland, discusses how a shift in axillary lymph node procedures has positively affected breast cancer patients.

Since the advent of the sentinel node biopsy there has been a dramatic movement away from routinely removing axillary nodes. Focusing primarily on the sentinel nodes as the only axillary node procedure has increased recovery time and reduced the risk of lymphedema for breast cancer patients.

It is becoming even more clear that node dissection is often not necessary after completing a sentinel node biopsy, even if some of the nodes are positive.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute